{
    "Trade/Device Name(s)": [
        "FastPack Control Kit"
    ],
    "Submitter Information": "Qualigen, Inc.",
    "510(k) Number": "K123725",
    "Predicate Device Reference 510(k) Number(s)": [
        "K960824",
        "K003095",
        "K052301"
    ],
    "Regulatory Class": "Class I, reserved",
    "Product Code(s)": [
        "JJY"
    ],
    "Summary Letter Date": "March 8, 2013",
    "Summary Letter Received Date": "February 11, 2013",
    "Submission Date": "February 5, 2013",
    "Regulation Number(s)": [
        "21 CFR 862.1660"
    ],
    "Regulation Name(s)": [
        "Quality control material"
    ],
    "Analyte Class(es)": [
        "chemistry",
        "endocrine"
    ],
    "Analyte(s)": [
        "Free Thyroxine (FT4)",
        "Human Chorionic Gonadotropin (hCG)",
        "Testosterone",
        "Total Prostate Specific Antigen (tPSA)",
        "Thyroid Stimulating Hormone (TSH)"
    ],
    "Specimen Type(s)": [
        ""
    ],
    "Specimen Container(s)": [
        ""
    ],
    "Instrument(s)/Platform(s)": [
        "FastPack System",
        "FastPack IP System"
    ],
    "Method(s)/Technology(ies)": [
        ""
    ],
    "Methodologies": [
        ""
    ],
    "Submission Type(s)": [
        "Control",
        "Quality control material"
    ],
    "Document Summary": "FDA 510(k) summary for FastPack Control Kit as a multi-analyte assayed quality control for FastPack and FastPack IP systems.",
    "Indications for Use Summary": "Assayed quality control for verifying accuracy and precision of FastPack and FastPack IP Systems in the quantitative determination of FT4, hCG, testosterone, tPSA, and TSH.",
    "fda_folder": "Clinical Chemistry"
}